If this works, and scales, then it will be fantastic. It will also be disruptive to the ~$450B diabetes industry.
Because I doubt type 2 diabetics would have much benefit from this.
Still, why not do it on the side of the finger? It has to be as updated as the tip, but it has a lot less nerve endings.